Regulation of inositol trisphosphate receptors

肌醇三磷酸受体的调节

基本信息

  • 批准号:
    10542722
  • 负责人:
  • 金额:
    $ 32.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-01-01 至 2024-12-31
  • 项目状态:
    已结题

项目摘要

Calcium is a universal messenger controlling a multitude of cellular responses including muscle contraction, exocytosis, memory, fertilization, metabolism, proliferation and cell death. Numerous hormones, neurotransmitters and growth factors stimulate the formation of inositol 1,4,5-trisphosphate ( IP3 ) which acts on a family of receptors ( IP3Rs ) located in the endoplasmic reticulum that function as ligand-gated Ca2+ channels. The depletion of intracellular Ca2+ stores also activates Ca2+ influx mechanisms in the plasma membrane. Thus, the interaction of IP3 with its receptor activates all phases of a Ca2+ signal. IP3Rs are regulated by Ca2+ and phosphorylation but the molecular basis of this regulation is poorly understood. Ca2+ released from IP3Rs is locally transmitted to the mitochondria and can stimulate metabolism, and in higher amounts, can also initiate cell death. Cancer cells have been proposed to be highly dependent on IP3R- mediated mitochondrial Ca2+ transfer for their survival. The advent of CRISPR/Cas-9 technology has allowed the genetic ablation of all three IP3R isoforms from HEK293 and HeLa cervix carcinoma cells. The proposal is centered on the use of these cell lines to a) study the adaptive mechanisms allowing the cells to survive in the complete absence of Ca2+ signaling and b) to take advantage of a null background for structure-function studies exploring the molecular mechanism by which IP3 opens the channel and the mechanism of feed-back regulation by Ca2+. The two specific aims are: 1] Characterize adaptive mechanisms in IP3R-3KO cells: The impact of a lack of Ca2+ regulation of metabolism will be investigated by measuring several bioenergetic parameters and 13C-tracer metabolism. Proliferation, cell-cycle status, cell death and transcriptional rewiring will be explored. 2A] How does IP3 open the channel? Chemical crosslinking/mass spectroscopy will be used to validate cryo-EM structures and monitor conformational changes mediated by IP3 in native IP3Rs. Mutagenesis of key residues will be used to test proposed allosteric mechanisms of gating. 2B] Identification of the Ca2+ regulatory sites in IP3Rs: Based on the most recent cryo-EM structures of IP3R1 and IP3R3 we have identified 3 clusters of negatively charged residues that are candidates for Ca2+ regulatory sites. Their functional role as stimulatory or inhibitory sites will be assessed by mutagenesis. The role of these sites will also be tested by mutagenesis of the Ca2+-insensitive IP3R from Capsaspora owczarzaki . The long-term goal of the proposal is to better understand the role of Ca2+signaling in normal cells, cancer cells and in inherited disorders inactivating IP3R function. The study should also provide fundamental mechanistic information on how these important channels work and are regulated.
钙是一种控制多种细胞反应的通用信使,包括肌肉收缩, 胞吐、记忆、受精、新陈代谢、增殖和细胞死亡。大量荷尔蒙, 神经递质和生长因子刺激肌醇1,4,5-三磷酸(IP3)的形成 内质网中作为配体门控钙离子的受体家族(IP3Rs)的研究 频道。细胞内钙库的耗尽也激活了血浆中的钙内流机制 薄膜。因此,IP3与其受体的相互作用激活了钙信号的所有阶段。IP3R是 受钙离子和磷酸化的调节,但这种调节的分子基础还不是很清楚。Ca2+ 从IP3Rs释放出来的物质局部传递到线粒体,可以刺激新陈代谢,在更高的 量多了,也会引发细胞死亡。癌细胞被认为高度依赖IP3R- 介导的线粒体钙离子转移为它们的生存。CRISPR/CAS-9技术的出现使得 HEK293和HeLa宫颈癌细胞三种IP3R亚型的基因消融该提案是 以这些细胞系的使用为中心a)研究允许细胞在 完全没有钙离子信号,以及b)利用结构功能的零背景 IP3开放通道的分子机制和反馈机制的研究 受钙离子的调节。两个具体目标是:1]表征IP3R-3KO细胞的适应机制: 缺乏钙离子调节新陈代谢的影响将通过测量几种生物能量来研究 参数和~(13)C示踪剂代谢。增殖、细胞周期状态、细胞死亡和转录重新连接 将会被探索。2A]IP3是如何打通频道的?将使用化学交联/质谱学 验证冷冻-EM结构并监测IP3在天然IP3R中介导的构象变化。 关键残基的突变将被用来测试拟议的门控变构机制。2B]识别 基于IP3R1和IP3R3WE的最新冷冻-EM结构 已经确定了3簇带负电荷的残基,这些残基是钙离子调控位点的候选者。他们的 作为刺激或抑制部位的功能作用将通过突变来评估。这些网站的作用将是 也可以通过诱变欧扎克辣椒对钙离子不敏感的IP3R进行检测。长期目标 为了更好地理解钙信号在正常细胞、癌细胞和遗传性细胞中的作用 紊乱使IP3R功能失活。研究还应提供有关以下方面的基本机制信息 这些重要渠道是如何运作和受到监管的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SURESH K JOSEPH其他文献

SURESH K JOSEPH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SURESH K JOSEPH', 18)}}的其他基金

Regulation of inositol trisphosphate receptors
肌醇三磷酸受体的调节
  • 批准号:
    9887459
  • 财政年份:
    2020
  • 资助金额:
    $ 32.12万
  • 项目类别:
Regulation of inositol trisphosphate receptors
肌醇三磷酸受体的调节
  • 批准号:
    10326833
  • 财政年份:
    2020
  • 资助金额:
    $ 32.12万
  • 项目类别:
Regulation of inositol trisphosphate receptors
肌醇三磷酸受体的调节
  • 批准号:
    10077856
  • 财政年份:
    2020
  • 资助金额:
    $ 32.12万
  • 项目类别:
Mechanism of Inositol Trisphosphate Action
三磷酸肌醇的作用机制
  • 批准号:
    8034977
  • 财政年份:
    2010
  • 资助金额:
    $ 32.12万
  • 项目类别:
IP3 Receptor Phosphorylation by Akt Kinase
Akt 激酶对 IP3 受体进行磷酸化
  • 批准号:
    6913966
  • 财政年份:
    2005
  • 资助金额:
    $ 32.12万
  • 项目类别:
IP3 Receptor Phosphorylation by Akt Kinase
Akt 激酶对 IP3 受体进行磷酸化
  • 批准号:
    7016345
  • 财政年份:
    2005
  • 资助金额:
    $ 32.12万
  • 项目类别:
BIOSYNTHESIS AND DEGRADATION OF IP3 RECEPTORS
IP3 受体的生物合成和降解
  • 批准号:
    2729619
  • 财政年份:
    1999
  • 资助金额:
    $ 32.12万
  • 项目类别:
BIOSYNTHESIS AND DEGRADATION OF IP3 RECEPTORS
IP3 受体的生物合成和降解
  • 批准号:
    6138676
  • 财政年份:
    1999
  • 资助金额:
    $ 32.12万
  • 项目类别:
BIOSYNTHESIS AND DEGRADATION OF IP3 RECEPTORS
IP3 受体的生物合成和降解
  • 批准号:
    6343038
  • 财政年份:
    1999
  • 资助金额:
    $ 32.12万
  • 项目类别:
BIOSYNTHESIS AND DEGRADATION OF IP3 RECEPTORS
IP3 受体的生物合成和降解
  • 批准号:
    6490242
  • 财政年份:
    1999
  • 资助金额:
    $ 32.12万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 32.12万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.12万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 32.12万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.12万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 32.12万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 32.12万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.12万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 32.12万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 32.12万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.12万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了